Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

aliskiren-amLODIPine

aliskiren-amLODIPine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Tekamlo TABLET, ORAL 150 mg-5 mg, 150 mg-10 mg, 300 mg-5 mg, 300 mg-10 mg    
VIEW MORE Dihydropyridines, Renin Inhibitors
CLASS
242808, 243240
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

aliskiren-amLODIPine (Tekamlo)                                                 

  • 150 mg-5 mg tablet oral                             
  • 150 mg-10 mg tablet oral                                                
  • 300 mg-5 mg tablet oral                                     
  • 300 mg-10 mg tablet oral

aliskiren (Tekturna) AND amLODIPine (Norvasc)

  • ONE 150 mg aliskiren PLUS ONE 5 mg amLODIPine
  • ONE 150 mg aliskiren PLUS ONE 10 mg amLODIPine
  • ONE 300 mg aliskiren PLUS ONE 5 mg amLODIPine
  • ONE 300 mg aliskiren PLUS ONE 10 mg amLODIPine

Reviewed: September 28, 2010

Last updated: Dec. 19, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved